Polio: The Crippling Disease We’re Close to Eradicating Forever
How Vaccines Brought a Paralyzing Virus to the Brink of Extinction
In 1952, polio paralyzed over 21,000 people in the United States alone, mostly children, in what became known as the worst polio epidemic in American history. Iron lungs—massive metal cylinders helping paralyzed patients breathe—filled hospital wards. Parents lived in terror each summer when polio cases surged, keeping children away from swimming pools, playgrounds, and public gatherings. President Franklin D. Roosevelt, himself paralyzed by polio, became the public face of this devastating disease. Polio seemed unstoppable, a terrifying force randomly striking down healthy children and leaving them paralyzed for life or dead.
Fast forward seven decades. In 2024, polio exists in only two countries worldwide—Pakistan and Afghanistan. This represents one of public health’s greatest triumphs—reducing polio cases by over 99.9% through global vaccination efforts. We stand tantalizingly close to making polio only the second human disease ever eradicated, following smallpox. Yet the final steps prove frustratingly difficult, with conflict, vaccine hesitancy, and logistical challenges preventing those last few virus strongholds from being eliminated.
According to the World Health Organization, poliomyelitis (polio) is a highly infectious viral disease that primarily affects young children, invading the nervous system and causing irreversible paralysis within hours. The poliovirus spreads from person to person, mainly through fecal-oral transmission in areas with poor sanitation. While most infections cause no symptoms or only mild illness, approximately 1 in 200 infections leads to irreversible paralysis, usually of the legs. Among those paralyzed, 5-10% die when breathing muscles become immobilized. Despite being incurable once infection occurs, polio is entirely preventable through vaccination. The Global Polio Eradication Initiative, launched in 1988 when polio paralyzed approximately 350,000 people annually across 125 countries, has reduced cases by more than 99.9%—saving an estimated 20 million people from paralysis.
Understanding Polio
Polio is caused by poliovirus, a highly contagious virus that spreads primarily through the fecal-oral route. In areas with poor sanitation, virus-contaminated water or food transmits infection. The virus can also spread through respiratory droplets when infected people cough or sneeze, though this is less common. After entering through the mouth, poliovirus multiplies in the intestines and throat, then spreads through the bloodstream. In most cases (about 95%), the immune system eliminates the virus without causing serious illness.
However, in approximately 1 in 200 infections, poliovirus invades the nervous system, attacking nerve cells that control muscles. This causes acute flaccid paralysis—sudden onset of weakness and loss of muscle tone, typically affecting legs but sometimes arms, breathing muscles, or swallowing muscles. Paralysis can develop within hours and is often permanent. Among paralyzed patients, 5-10% die when paralysis affects breathing muscles and medical support isn’t available.
Three types of wild poliovirus exist—type 1, type 2, and type 3. Through vaccination efforts, type 2 was eradicated in 1999, and type 3 was eradicated in 2019. Only wild poliovirus type 1 now circulates, exclusively in Pakistan and Afghanistan. This makes eradication tantalizingly close—if transmission of this final virus type can be stopped, polio will join smallpox as the only human diseases ever eradicated.
Most people infected with poliovirus show no symptoms at all (approximately 72% of infections), making disease detection challenging since silent carriers can still transmit virus to others. About 24% develop minor symptoms including fever, fatigue, headache, vomiting, neck stiffness, and limb pain lasting 2-5 days—easily mistaken for flu or other common illnesses. About 4% develop viral meningitis causing neck stiffness, headache, and back/leg pain. Less than 1% develop paralytic polio causing sudden paralysis, permanent disability, and risk of death if breathing muscles affected.
Like pneumonia and pertussis, polio disproportionately affects young children, though anyone can contract it.
Polio’s Historical Impact
Before vaccines, polio caused devastating epidemics worldwide, particularly in temperate climates where cases surged during summer and fall. The disease struck seemingly randomly—children playing together one day, one paralyzed the next—creating profound fear. Ironically, improved sanitation in developed countries initially increased polio’s impact. In areas with poor sanitation, most children encountered poliovirus as infants while still protected by maternal antibodies, experiencing asymptomatic infections that provided lifelong immunity. As sanitation improved, children’s first exposure occurred at older ages without maternal antibody protection, increasing paralysis risk.
The 1950s polio epidemics in the United States and Europe traumatized entire societies. Hospitals established dedicated polio wards filled with children in iron lungs—mechanical ventilators encasing patients from neck to feet, using pressure changes to force breathing. The “March of Dimes” campaign, originally founded by President Roosevelt to fight polio, raised millions for research and treatment. Swimming pools closed during epidemics. Parents avoided public places during summer “polio season.”
The development of polio vaccines transformed this landscape. Jonas Salk developed the first successful polio vaccine in 1955—an inactivated (killed) virus vaccine given by injection. Mass vaccination campaigns dramatically reduced polio cases in developed countries within years. Albert Sabin subsequently developed an oral polio vaccine using weakened live virus, easier to administer and better at preventing virus spread in communities. These vaccines became cornerstones of childhood immunization worldwide.
The Path to Eradication
In 1988, when WHO launched the Global Polio Eradication Initiative (GPEI), polio paralyzed approximately 350,000 people annually across 125 countries on all inhabited continents. The eradication strategy combined several approaches: routine immunization ensuring all children receive polio vaccines as part of standard childhood vaccination schedules, supplementary immunization activities (SIAs) conducting mass campaigns vaccinating all children under five regardless of vaccination history during “national immunization days,” surveillance for acute flaccid paralysis (AFP) detecting and investigating every case of sudden paralysis in children to identify polio quickly, and targeted “mop-up” campaigns in areas where poliovirus continues circulating.
This multipronged approach achieved remarkable success. By 2000, polio was eliminated from the Western Pacific region. By 2002, the European region was certified polio-free. South-East Asia achieved certification in 2014 after India—long considered the most challenging country—stopped transmission through massive vaccination efforts. Africa achieved certification in 2020 after Nigeria, the last endemic African country, interrupted transmission. This left only two countries—Pakistan and Afghanistan—with continuing wild poliovirus type 1 transmission.
The progress represents staggering achievement. Polio cases dropped from 350,000 in 1988 to just a handful annually now—a reduction of over 99.9%. An estimated 20 million people who would have been paralyzed can walk because of polio vaccination. The effort involved unprecedented coordination—WHO, UNICEF, Rotary International, the U.S. Centers for Disease Control and Prevention, the Bill & Melinda Gates Foundation, and countless national governments and volunteers working together for decades.
Like maternal health and newborn health improvements, polio elimination demonstrates what’s achievable through sustained global commitment and adequate resources.
The Final Challenges
If polio eradication is so close, why hasn’t it been achieved? Several interconnected challenges prevent the final push. Ongoing conflict in Pakistan and Afghanistan disrupts vaccination campaigns, makes some areas inaccessible to vaccination teams, and destroys health infrastructure. Vaccinators have been attacked and killed in both countries by groups opposing vaccination, sometimes viewing campaigns as Western interference. This insecurity prevents reaching all children.
Vaccine hesitancy and refusal in some communities, fueled by misinformation, religious concerns, or distrust of government/outsiders, creates immunity gaps where poliovirus can circulate. Population movement across the Pakistan-Afghanistan border enables virus spread between countries, requiring coordinated efforts that conflict complicates. Weak health systems struggle to maintain high routine immunization coverage between mass campaigns, leaving some children unvaccinated.
Additionally, vaccine-derived poliovirus (VDPV) poses challenges. The oral polio vaccine contains weakened live virus that multiplies in intestines, providing immunity and spreading to others through fecal contamination—beneficial in high-transmission settings. However, in areas with low vaccination coverage and poor sanitation, the weakened vaccine virus can circulate person-to-person for extended periods, eventually mutating to regain the ability to cause paralysis. These vaccine-derived viruses have caused outbreaks in areas with inadequate immunization coverage. A novel oral polio vaccine type 2 (nOPV2), designed to be more genetically stable and less likely to revert to harmful forms, is being deployed to combat this.
Like plague control requiring environmental management beyond individual interventions, polio eradication demands addressing complex sociopolitical factors.
Polio Vaccines
Two main polio vaccine types exist. Inactivated poliovirus vaccine (IPV), developed by Jonas Salk, contains killed poliovirus given by injection. It’s extremely safe, cannot cause vaccine-associated paralysis, provides excellent individual protection, and is used in most developed countries. However, it’s more expensive, requires trained health workers for injection, and provides less intestinal immunity so doesn’t prevent virus transmission as effectively as OPV.
Oral poliovirus vaccine (OPV), developed by Albert Sabin, contains weakened live poliovirus given as drops in the mouth. It’s inexpensive, easy to administer (no injection needed), provides excellent intestinal immunity preventing virus transmission, and creates “herd immunity” as vaccine virus spreads to unvaccinated people. However, in rare cases (approximately 1 in 2.7 million doses), it can cause vaccine-associated paralytic polio in immunocompromised individuals. More significantly, in areas with low vaccination coverage, the vaccine virus can circulate and mutate, causing vaccine-derived poliovirus outbreaks.
The eradication strategy uses both vaccines strategically—OPV in endemic areas for its superior ability to stop transmission, while many countries have switched to IPV-only schedules once polio is eliminated from their region, eliminating vaccine-derived virus risk while maintaining population immunity.
What Happens After Eradication?
Once wild poliovirus transmission is interrupted globally and sufficient time passes to ensure no hidden circulation, WHO will certify global polio eradication. But eradication isn’t the endpoint—careful management prevents reintroduction. All countries must maintain high polio vaccination coverage to prevent outbreaks if virus somehow reappears. Laboratory containment will ensure poliovirus is stored securely only in designated high-security facilities, destroying virus stocks elsewhere to prevent accidental release.
The oral polio vaccine containing live virus will eventually be phased out globally once wild and vaccine-derived viruses are eliminated, transitioning entirely to IPV. Surveillance must continue detecting any polio resurgence rapidly. The infrastructure, expertise, and partnerships built for polio eradication can be leveraged for other health priorities—routine immunization strengthening, disease surveillance systems, and emergency response capacity.
Hope for the Future
Despite challenges, polio eradication remains achievable. Innovative tools including new vaccines, improved surveillance methods, and genetic sequencing tracking virus transmission enhance capabilities. Increasing political commitment and funding address resource gaps. Community engagement strategies build trust in resistant populations. Improved security allows vaccination in previously inaccessible areas.
Every child deserves protection from this devastating disease. When the last case of wild poliovirus is detected, celebrations will be tempered by remembering the millions paralyzed before vaccines became available and the thousands of dedicated workers—many who risked and some who lost their lives—making eradication possible. Polio eradication will demonstrate that global cooperation, sustained commitment, and scientific innovation can eliminate diseases that once seemed unconquerable, providing hope for tackling other global health challenges.
Frequently Asked Questions (FAQs)
Polio (poliomyelitis) is a highly infectious viral disease caused by poliovirus that primarily affects young children, invading the nervous system and potentially causing irreversible paralysis within hours. It spreads person-to-person mainly through fecal-oral transmission in areas with poor sanitation—virus-contaminated water or food transmits infection. It can also spread through respiratory droplets. Most infections (95%) cause no symptoms or only mild illness, but approximately 1 in 200 infections leads to irreversible paralysis, usually of legs. Among paralyzed patients, 5-10% die when breathing muscles become immobilized. Polio is incurable once infection occurs but is entirely preventable through vaccination.
Polio cases dropped from 350,000 annually in 1988 to just handful now—over 99.9% reduction. Wild poliovirus now circulates only in Pakistan and Afghanistan. Final eradication faces challenges including ongoing conflict disrupting vaccination campaigns and making areas inaccessible, attacks on vaccination workers in both countries, vaccine hesitancy in some communities fueled by misinformation or distrust, population movement across Pakistan-Afghanistan border enabling virus spread, weak health systems struggling to maintain high vaccination coverage, and vaccine-derived poliovirus outbreaks in areas with inadequate immunization. Despite these obstacles, continued efforts, innovative tools, and increasing political commitment make complete eradication achievable.
Two main types exist: Inactivated poliovirus vaccine (IPV) contains killed virus given by injection—extremely safe, cannot cause paralysis, provides excellent individual protection, used in developed countries. However, it’s more expensive and doesn’t prevent virus transmission as effectively. Oral poliovirus vaccine (OPV) contains weakened live virus given as mouth drops—inexpensive, easy to administer, provides excellent intestinal immunity preventing transmission, creates herd immunity. However, rarely can cause vaccine-associated paralysis (1 in 2.7 million doses), and in areas with low vaccination coverage, vaccine virus can circulate and mutate causing outbreaks. Eradication strategy uses OPV in endemic areas for superior transmission prevention, while polio-free countries use IPV-only schedules.
Yes, though risk is very low. Unvaccinated or under-vaccinated people remain vulnerable if exposed to poliovirus through travel to endemic areas, contact with infected travelers from endemic areas, or laboratory exposure (extremely rare). This is why maintaining high vaccination coverage remains critical even in polio-free countries—herd immunity protects populations and prevents outbreaks if virus is reintroduced. Several countries have experienced poliovirus importations causing small outbreaks in recent years when virus from endemic areas spread to populations with immunity gaps. Once global eradication is certified and sufficient time passes, risk will essentially disappear, but vigilance must continue.
After wild poliovirus is eradicated globally and vaccine-derived viruses are eliminated, polio vaccination strategies will evolve: (1) Oral polio vaccine (containing live virus) will be phased out globally since risk of vaccine-derived virus outbreaks will outweigh benefits once wild virus is gone; (2) Countries will transition to IPV-only schedules or potentially stop polio vaccination entirely generations after eradication is certified; (3) High vaccination coverage must be maintained initially to prevent outbreaks if virus somehow reappears; (4) Strict laboratory containment will ensure poliovirus is stored only in designated high-security facilities; (5) Surveillance will continue detecting any polio resurgence. The timeline for reducing or stopping vaccination will depend on global risk assessment and ensuring no hidden virus circulation exists.
Reference
- World Health Organization. (2024). Poliomyelitis (polio). Retrieved from https://www.who.int/health-topics/poliomyelitis
- World Health Organization. (2024). Poliomyelitis – Fact Sheet. Retrieved from https://www.who.int/news-room/fact-sheets/detail/poliomyelitis
- Global Polio Eradication Initiative. (2024). Retrieved from https://polioeradication.org/
- Centers for Disease Control and Prevention. (2024). Polio. Retrieved from https://www.cdc.gov/polio/
- Observer Voice. Pneumonia: The Infectious Lung Disease Killing 740,000 Children. Retrieved from https://observervoice.com/pneumonia-symptoms-treatment-prevention-children-vaccination/
- Observer Voice. Pertussis: The Whooping Cough Still Killing Thousands. Retrieved from https://observervoice.com/pertussis-whooping-cough-vaccination-prevention-infants/
Disclaimer: This article is an adaptation of publicly available information from WHO’s Polio
health topic page (WHO, Geneva. Licence: CC BYNC-SA 3.0 IGO). WHO is not responsible for the
content or accuracy of this adaptation. This content is for informational and educational purposes
only and does not constitute medical advice. ObserverVoice.com is a news and information platform
— not a healthcare provider.
Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.
